Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

ICU breathing device guidelines sought by international experts

NCT ID NCT07420946

Knowledge-focused Sponsor: Medipol University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study brings together 30 healthcare experts from around the world to agree on the best ways to use a machine called Mechanical Insufflation-Exsufflation (MI-E) in intensive care units. MI-E helps clear mucus from the lungs, but there are no standard rules for its use in critically ill patients. Through multiple rounds of questionnaires, the experts will vote on statements to create practical guidelines for safer and more consistent care.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this could lead to standardized guidelines for using a breathing device in intensive care, improving patient safety and care consistency.
What could go wrong
This is a consensus study based on expert opinion, not a clinical trial testing a treatment. The guidelines may not be universally accepted or may need updating as new evidence emerges.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 30 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jun 2026

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

experts on MI-E

Ages

Children (under 18), adults (18 to 64) and older adults (65 and over)

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Healthcare professionals with documented clinical experience in critical care medicine, pulmonology, anesthesiology, respiratory therapy, or physiotherapy with involvement in airway clearance strategies. * Demonstrated experience or recognized expertise in the clinical use of MI-E, either in critically ill patients or in patients with complex respiratory conditions. * A minimum of 5 years of clinical experience in their respective field, or a proven academic or clinical contribution related to MI-E. * Willingness to participate in multiple Delphi rounds and to provide informed consent. * Ability to complete the questionnaires in English. Exclusion Criteria: * Lack of direct clinical or academic experience related to MI-E or airway clearance techniques. * Inability or unwillingness to provide informed consent. * Failure to complete the first Delphi round after formal invitation and consent. * Withdrawal of consent at any stage of the Delphi process.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Airway clearance are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Critical Illness

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Airway clearance Consensus Critical care Critical care, intensive care Critical illness Delphi study Mechanical insufflation-exsufflation Mechanical insufflation-exsufflation session ( with cough assist)

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    4 sites in 3 countries. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Hospital General Universitario Morales Meseguer

    RECRUITING

    Murcia, Spain

  • Monaldi Hospital A.O.R.N. dei Colli

    RECRUITING

    Naples, Italy

  • University of Naples Federico II

    RECRUITING

    Naples, Italy

  • İstanbul Medipol University

    RECRUITING

    Istanbul, Istanbul, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.